BioRestorative Therapies, Inc. (BRTX)
Nasdaq: BRTX · CIK 0001505497 · United States
Every official BioRestorative Therapies, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BRTX filings
BioRestorative Therapies, Inc. documents
- BioRestorative Therapies, Inc. 10-K 2026BRTX 10-K 2026: annual report for fiscal 2026
- BioRestorative Therapies, Inc. 10-K 2025BRTX 10-K 2025: annual report for fiscal 2025
- BioRestorative Therapies, Inc. 10-K 2024BRTX 10-K 2024: annual report for fiscal 2024
- BioRestorative Therapies, Inc. 10-K 2023BRTX 10-K 2023: annual report for fiscal 2023
- BioRestorative Therapies, Inc. 10-K 2022BRTX 10-K 2022: annual report for fiscal 2022
- BioRestorative Therapies, Inc. 10-Q 2026BRTX 10-Q 2026: quarterly report for fiscal 2026
- BioRestorative Therapies, Inc. 10-Q 2025BRTX 10-Q 2025: quarterly report for fiscal 2025
- BioRestorative Therapies, Inc. 10-Q 2024BRTX 10-Q 2024: quarterly report for fiscal 2024
- BioRestorative Therapies, Inc. 10-Q 2023BRTX 10-Q 2023: quarterly report for fiscal 2023
- BioRestorative Therapies, Inc. 10-Q 2022BRTX 10-Q 2022: quarterly report for fiscal 2022
- BioRestorative Therapies, Inc. 8-K 2026BRTX 8-K 2026: current report for fiscal 2026
- BioRestorative Therapies, Inc. 8-K 2025BRTX 8-K 2025: current report for fiscal 2025
- BioRestorative Therapies, Inc. 8-K 2024BRTX 8-K 2024: current report for fiscal 2024
- BioRestorative Therapies, Inc. 8-K 2023BRTX 8-K 2023: current report for fiscal 2023
- BioRestorative Therapies, Inc. 8-K 2022BRTX 8-K 2022: current report for fiscal 2022
- BioRestorative Therapies, Inc. DEF 14A 2026BRTX DEF 14A 2026: proxy statement for fiscal 2026
- BioRestorative Therapies, Inc. DEF 14A 2025BRTX DEF 14A 2025: proxy statement for fiscal 2025
- BioRestorative Therapies, Inc. DEF 14A 2024BRTX DEF 14A 2024: proxy statement for fiscal 2024
- BioRestorative Therapies, Inc. DEF 14A 2023BRTX DEF 14A 2023: proxy statement for fiscal 2023
- BioRestorative Therapies, Inc. DEF 14A 2022BRTX DEF 14A 2022: proxy statement for fiscal 2022
- BioRestorative Therapies, Inc. Form 4 2026BRTX Form 4 2026: insider trading filing for fiscal 2026
- BioRestorative Therapies, Inc. Form 4 2025BRTX Form 4 2025: insider trading filing for fiscal 2025
- BioRestorative Therapies, Inc. Form 4 2024BRTX Form 4 2024: insider trading filing for fiscal 2024
- BioRestorative Therapies, Inc. Form 4 2023BRTX Form 4 2023: insider trading filing for fiscal 2023
- BioRestorative Therapies, Inc. Form 4 2022BRTX Form 4 2022: insider trading filing for fiscal 2022
- BioRestorative Therapies, Inc. S-1 2026BRTX S-1 2026: registration statement for fiscal 2026
- BioRestorative Therapies, Inc. S-1 2025BRTX S-1 2025: registration statement for fiscal 2025
- BioRestorative Therapies, Inc. S-1 2024BRTX S-1 2024: registration statement for fiscal 2024
- BioRestorative Therapies, Inc. S-1 2023BRTX S-1 2023: registration statement for fiscal 2023
- BioRestorative Therapies, Inc. S-1 2022BRTX S-1 2022: registration statement for fiscal 2022
- BioRestorative Therapies, Inc. 13F 2026BRTX 13F 2026: institutional holdings for fiscal 2026
- BioRestorative Therapies, Inc. 13F 2025BRTX 13F 2025: institutional holdings for fiscal 2025
- BioRestorative Therapies, Inc. 13F 2024BRTX 13F 2024: institutional holdings for fiscal 2024
- BioRestorative Therapies, Inc. 13F 2023BRTX 13F 2023: institutional holdings for fiscal 2023
- BioRestorative Therapies, Inc. 13F 2022BRTX 13F 2022: institutional holdings for fiscal 2022
More companies